Therefore, we delivered EGFR siRNA to head and neck tumor cells using lipid-based LCP NPs with AEAA targeting ligands formulated on the outer layer portion of the nanoparticles to target the over-expressed sigma receptors [11,12] on the HNSCC cell surface. The gene discussed is EGFR; the disease is head and neck squamous cell carcinoma.